Margarita Kushnir

483 total citations
19 papers, 310 citations indexed

About

Margarita Kushnir is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Immunology. According to data from OpenAlex, Margarita Kushnir has authored 19 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Internal Medicine, 7 papers in Cardiology and Cardiovascular Medicine and 5 papers in Immunology. Recurrent topics in Margarita Kushnir's work include Venous Thromboembolism Diagnosis and Management (11 papers), Atrial Fibrillation Management and Outcomes (5 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (4 papers). Margarita Kushnir is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (11 papers), Atrial Fibrillation Management and Outcomes (5 papers) and Neutrophil, Myeloperoxidase and Oxidative Mechanisms (4 papers). Margarita Kushnir collaborates with scholars based in United States and Israel. Margarita Kushnir's co-authors include Henny H. Billett, Yun Young Choi, Wenzhu Mowrey, Devika Rao, Ruth Eisenberg, Seda S. Tolu, Kenji Ikemura, Shafia Rahman, Eran Bellin and Jesus D. Gonzalez‐Lugo and has published in prestigious journals such as Blood, Neurology and Journal of General Internal Medicine.

In The Last Decade

Margarita Kushnir

18 papers receiving 302 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Margarita Kushnir United States 8 178 153 86 44 37 19 310
Laura Franco Italy 12 235 1.3× 214 1.4× 34 0.4× 34 0.8× 97 2.6× 25 388
Inmaculada Roldán Spain 11 125 0.7× 236 1.5× 111 1.3× 62 1.4× 60 1.6× 31 387
Vincent Mémier France 7 52 0.3× 50 0.3× 56 0.7× 33 0.8× 28 0.8× 9 201
Jorge del Toro‐Cervera Spain 7 128 0.7× 101 0.7× 21 0.2× 10 0.2× 35 0.9× 15 178
Hooman Poor United States 9 87 0.5× 95 0.6× 146 1.7× 67 1.5× 49 1.3× 18 405
Shin-Yup Lee South Korea 12 206 1.2× 99 0.6× 30 0.3× 13 0.3× 43 1.2× 26 389
Carlos Andrés Quezada Spain 8 97 0.5× 109 0.7× 32 0.4× 12 0.3× 58 1.6× 16 280
Bernas Altıntaş Türkiye 10 53 0.3× 193 1.3× 21 0.2× 14 0.3× 71 1.9× 33 269
Irfan Moinuddin United States 6 99 0.6× 68 0.4× 20 0.2× 14 0.3× 105 2.8× 14 272
Sarah Barsam United Kingdom 7 97 0.5× 103 0.7× 12 0.1× 10 0.2× 38 1.0× 8 268

Countries citing papers authored by Margarita Kushnir

Since Specialization
Citations

This map shows the geographic impact of Margarita Kushnir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margarita Kushnir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margarita Kushnir more than expected).

Fields of papers citing papers by Margarita Kushnir

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margarita Kushnir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margarita Kushnir. The network helps show where Margarita Kushnir may publish in the future.

Co-authorship network of co-authors of Margarita Kushnir

This figure shows the co-authorship network connecting the top 25 collaborators of Margarita Kushnir. A scholar is included among the top collaborators of Margarita Kushnir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margarita Kushnir. Margarita Kushnir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Kushnir, Margarita, et al.. (2024). Acute renal thrombotic microangiopathy caused by eltrombopag and romiplostim in a patient with myelodysplastic syndromes (MDS) and underlying antiphospholipid syndrome. European Journal of Case Reports in Internal Medicine. 11(7). 4564–4564. 1 indexed citations
2.
Yin, David, et al.. (2023). Identifying Neutrophil Extracellular Traps (NETs) in Blood Samples Using Peripheral Smear Autoanalyzers. Life. 13(3). 623–623. 1 indexed citations
3.
Kushnir, Margarita, Radhika Gali, Mariam Alexander, & Henny H. Billett. (2022). Direct oral Xa inhibitors for the treatment of venous thromboembolism after bariatric surgery. Blood Advances. 7(2). 224–226. 5 indexed citations
4.
Goel, Swati, et al.. (2021). Thrombosis in myeloproliferative neoplasms: Treatment outcomes of direct oral anticoagulants and vitamin K antagonists. Research and Practice in Thrombosis and Haemostasis. 5(6). e12574–e12574. 7 indexed citations
5.
6.
Kushnir, Margarita, et al.. (2021). Saddle Pulmonary Embolism: Demographics, Clinical Presentation, and Outcomes. Critical Care Explorations. 3(6). e0437–e0437. 10 indexed citations
7.
Ikemura, Kenji, et al.. (2020). Neutrophilic Extracellular Traps (NETs); A Subset of Smudge Cells Identifiable by Peripheral Smear Autoanalyzers in the Rising Era of Artificial Intelligence. American Journal of Clinical Pathology. 154(Supplement_1). S10–S11. 1 indexed citations
8.
Billett, Henny H., James Szymanski, Kenji Ikemura, et al.. (2020). Anticoagulation in COVID-19: Effect of Enoxaparin, Heparin, and Apixaban on Mortality. Thrombosis and Haemostasis. 120(12). 1691–1699. 106 indexed citations
9.
Billett, Henny H., Morayma Reyes Gil, James Szymanski, et al.. (2020). Anticoagulation in COVID-19: Effect of Enoxaparin, Heparin and Apixaban on Mortality. SSRN Electronic Journal. 7 indexed citations
10.
Kushnir, Margarita, Yun Young Choi, Ruth Eisenberg, et al.. (2019). Efficacy and safety of direct oral factor Xa inhibitors compared with warfarin in patients with morbid obesity: a single-centre, retrospective analysis of chart data. The Lancet Haematology. 6(7). e359–e365. 103 indexed citations
11.
Goel, Swati, et al.. (2019). Direct Oral Anticoagulants for Prevention of Recurrent Thrombosis in Myeloproliferative Neoplasms. Blood. 134(Supplement_1). 4193–4193. 6 indexed citations
12.
Billett, Henny H., et al.. (2019). Neutrophil Extracellular Traps (NETs) Are a Subset of Smudge Cells Identifiable By Peripheral Smear Autoanalyzers. Blood. 134(Supplement_1). 2321–2321.
13.
Kushnir, Margarita, Radhika Gali, Mariam Alexander, & Henny H. Billett. (2019). Efficacy and Safety of Direct Oral Factor Xa Inhibitors in Patients after Bariatric Surgery. Blood. 134(Supplement_1). 2439–2439. 7 indexed citations
14.
Kushnir, Margarita, Yun Young Choi, Ruth Eisenberg, et al.. (2018). Efficacy and Safety of Direct Oral Factor Xa Inhibitors in 795 Morbidly Obese Patients. Blood. 132(Supplement 1). 423–423. 3 indexed citations
15.
Choi, Yun Young, Margarita Kushnir, & Henny H. Billett. (2017). Apixaban Is Safe and Effective in Morbidly Obese Patients: A Retrospective Analysis of 390 Patients with BMI ≥40. Blood. 130. 1105–1105. 16 indexed citations
16.
Kushnir, Margarita, Hillel W. Cohen, & Henny H. Billett. (2016). Persistent neutrophilia is a marker for an increased risk of venous thrombosis. Journal of Thrombosis and Thrombolysis. 42(4). 545–551. 22 indexed citations
17.
Park, Doyun, et al.. (2015). Treatment with Dalteparin is Associated with a Lower Risk of Bleeding Compared to Treatment with Unfractionated Heparin in Patients with Renal Insufficiency. Journal of General Internal Medicine. 31(2). 182–187. 10 indexed citations
18.
Kushnir, Margarita, Hillel W. Cohen, & Henny H. Billett. (2012). Chronic Neutrophilia: A Risk Factor for VTE?.. Blood. 120(21). 2249–2249. 1 indexed citations
19.
Drory, Vivian E., Asia Shapira, Amos D. Korczyn, et al.. (1998). Antineurofilament antibodies in postpolio syndrome. Neurology. 51(4). 1193–1195. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Laura Franco Breakdown of academic impact, for papers by Inmaculada Roldán Breakdown of academic impact, for papers by Vincent Mémier Breakdown of academic impact, for papers by Jorge del Toro‐Cervera Breakdown of academic impact, for papers by Hooman Poor Breakdown of academic impact, for papers by Shin-Yup Lee Breakdown of academic impact, for papers by Carlos Andrés Quezada Breakdown of academic impact, for papers by Bernas Altıntaş Breakdown of academic impact, for papers by Irfan Moinuddin Breakdown of academic impact, for papers by Sarah Barsam
Rankless by CCL
2026